Yeasts isolated from frequently in-patients and out-patients

• Autorzy: Dynowska M. , Ejdys E. , Biedunkiewicz A. , Kubiak D. , Sucharzewska E. , Roslan M.
• Języki publikacji: EN

Abstrakty

EN

The paper is a part of a general mycological monitoring study of nosocomial infections. Differences in the species composition and drug resistance of fungi isolated from in-patients and out-patients prompted an analysis of this topic. The studies were conducted with fungi from the collection of the Department of Mycology, University of Warmia and Mazury in Olsztyn, that were isolated from the oral cavity, sputum, bronchoscopic fluid, anus and skin from 100 in-patients and 100 out-patients. Laboratory analyses, including species categorization of fungi, were performed according to routine mycological diagnostics. Drug sensitivity to fluconazole and nystatin was tested with the disc diffusion method. In the group of in-patients, a wider taxonomic diversity of fungi (12 species) was found in comparison with the out-patients (7 species) and 31 cases of multifocal infections were recorded, while in the second group the number of the latter was only six. In all patients, C. albicans were predominant, constituting the largest proportion in focal infections in all patients and in multifocal infections in the in-patients. In the latter, over a half of the examined individuals were resistant to fluconazole (C. glabrata and C. krusei – 80%, C. tropicalis and S. capsularis – 60%, C. guilliermondii – 50%) and nystatin (T. beigelii – 80%, C. krusei and C. tropicalis – 50%). Substantially lower drug resistance of fungi was recorded in the out-patients. The hospital environment is an abundant reservoir of different fungal species with significantly greater expansiveness and aggressiveness compared to the environment outside a hospital.

Słowa kluczowe

EN

yeast; isolation; in-patient; out-patient; patient; fluconazole; nystatin; nosocomial infection

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2014
• Tom: 60
• Numer: 3
• Opis fizyczny: p.199-206,fig.,ref.

Twórcy

autor

Dynowska M.

• Department of Mycology, Faculty of Biology and Biotechnology, University of Warmia and Mazury in Olsztyn, Oczapowskiego 1A, 10-917 Olsztyn, Poland

autor

Ejdys E.

• Department of Mycology, Faculty of Biology and Biotechnology, University of Warmia and Mazury in Olsztyn, Oczapowskiego 1A, 10-917 Olsztyn, Poland

autor

Biedunkiewicz A.

• Department of Mycology, Faculty of Biology and Biotechnology, University of Warmia and Mazury in Olsztyn, Oczapowskiego 1A, 10-917 Olsztyn, Poland

autor

Kubiak D.

• Department of Mycology, Faculty of Biology and Biotechnology, University of Warmia and Mazury in Olsztyn, Oczapowskiego 1A, 10-917 Olsztyn, Poland

autor

Sucharzewska E.

• Department of Mycology, Faculty of Biology and Biotechnology, University of Warmia and Mazury in Olsztyn, Oczapowskiego 1A, 10-917 Olsztyn, Poland

autor

Roslan M.

• 2Independent Public Complex of Tuberculosis and Lung Diseases, Jagiellonska 78, 10-357 Olsztyn, Poland

Bibliografia

• [1] Kurtzman C.P., Fell J.N., Bekhout T. 2011. The yeasts. A taxonomic study. Fifth edition. Elsevier, Tokyo.
• [2] Kurnatowska A., Kurnatowski P. 2006. Mikologia medyczna. Promedi, Łódź.
• [3] Richardson D.M., Warnock D. 1995. Fungal infection. Diagnosis and management. Blackwell Scientific Publication, Oxford.
• [4] Dynowska M., Góralska K., Troska P., Barańska G., Biedunkiewicz A., Ejdys E., Sucharzewska E. 2011. Results of long-standing mycological analyses of biological materials originating from selected organ ontocenoses – yeast and yeast-like fungi. Wiadomości Parazytologiczne 57: 97-102.
• [5] Dynowska M., Biedunkiewicz A. 2001. Grzyby chorobotwórcze o wzrastającej ekspansywności. Wiadomości Parazytologiczne 47: 609-613.
• [6] Dynowska M., Ejdys E., Kisicka I. 2004. Susceptibility to antifungal agents of yeast – like fungi and yeast isolated from people with multifocal infections. Mikologia Lekarska 11: 15-19.
• [7] Batura-Gabriel H. 2001. Wieloogniskowe występowanie i aktywność hydrolityczna grzybów z rodzaju Candida wyizolowanych od chorych na raka płuc. Wiadomości Parazytologiczne 47: 623-628.
• [8] Dynowska M., Góralska K., Szewczyk T., Buczyńska E. 2008. Godne uwagi gatunki grzybów izolowane z przewodu pokarmowego osób poddanych endoskopii – badania rekonesansowe. Mikologia Lekarska 15: 67-70.
• [9] Biedunkiewicz A. 2001. Dynamics of human respiratory system mycoflora. Acta Mycologica 36: 211-239.
• [10] Dynowska M., Biedunkiewicz A., Sucharzewska E. 2002. Participation of yeast-like fungi in respiratory system diseases tuberculosis and neoplasms. Acta Mycologica 37: 103-108.
• [11] Hube B. 2004. From commensal to pathogen: stageand tissue-specific gene expression of Candida albicans. Current Opinion in Microbiology 7: 336-341.
• [12] Verthalis I., Meunier F. 1995. Invasive fungal infections in cancer patients. Prophylaxis of fungal infections. Bailliére’s Clinical Infection Diseases 2: 157-177.
• [13] Dynowska M., Góralska K., Rosłan M. 2008. Udział grzybów drożdżopodobnych w zakażeniach szpitalnych. Mikologia Lekarska 15: 151-154.
• [14] De Hoog G.S., Guarro J.M., Figueras J.G.M.J. 2000. Atlas of Clinical Fungi. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
• [15] Kreger-van Rij N.J.W. (Eds.) 1984. The yeast. A taxonomical study. Elsevier Science Publ. B.V., Amsterdam.
• [16] Kurtzman C.P., Fell J.N. 2000. The yeast. A taxonomical study. Elsevier, Amsterdam.
• [17] Chiou C.C., Groll A.H., Walsh T.J. 2000. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 5: 120-135.
• [18] Garcia-Marlos P., Galán-Sánches F., Marin-Casanova P., Mira-Gotiéres J. 1996. Systemic mycosis in a general hospital (1992-1995). Mikologia Lekarska 3: 163-165.
• [19] Kurnatowski P., Wieczorek A., Gorzyński T., Tyczkowska-Sieroń E. 2005. Zakażenia grzybicze pacjentów hospitalizowanych na Oddziale Intensywnej Terapii. Wiadomości Parazytologiczne 51: 23-27.
• [20] Maciejewska A., Kwaśniewska J., Jaskółowska A. 2005. Prevalence of fungal strains of Candida in patients with type 2 diabetes mellitus treated in the outpatient department and hospitalized due to diabetes on its complication. Mikologia Lekarska 12: 243-248.
• [21] Krajewska-Kułak E., Lewko J., Rolka H., Łukaszuk C., Karczewski J., Niczyporuk W., Zachowicz A. 2005. Grzybicze zakażenia szpitalne – narastający problem. Mikologia Lekarska 7: 159-163.
• [22] Rolka H., Krajewska- Kułak E., Szepietowski J., Łukaszuk C., Kowalczuk K., Klimaszewska K., Baranowska A., Jankowiak B., Krajewska K. 2006. Analysis of occurrence of mushrooms in rooms of block operating. Mikologia Lekarska 13: 301-305.
• [23] Pappas P.G., Rex J.H., Sobel J.D., Filler S.G. 2004. Guidelines for treatment of Candidasis. Clinical Infectious Diseases 38: 161-189.
• [24] Chakrabarti A., Shivaprakash M.R. 2005. Microbiology of systemic infections. Journal of Postgraduate Medicine 51, Suppl S: 20-26.
• [25] Dynowska M., Biedunkiewicz A., Ejdys E., Sucharzewska E., Rosłan M. 2013. Fungi of the genus Trichosporon isolated from the skin in hospitalized patients. Acta Mycologica 48: 145-151.
• [26] Connel J.H., Slatyer R.O. 1977. Mechanisms of succession in natural communities and their role in community stability and organization. American Naturalist 111: 1119-1144.
• [27] Groll A.H., Piscitelii S.C., Walsh T.J. 2001. Antifungal pharmacodynamics: concentration effect relationships in vitro and in vivo. Pharmacotherapy 21: 133-148.
• [28] Kontoyiannis D.P., Mantadakis E., Samonis G. 2003. Systemic mycoses in the immunocompromised host: an update in antifungal therapy. Journal Hospital Infection 53: 243-258.
• [29] Pawlik B., Macura A. 1996. Wrażliwość grzybów izolowanych z materiałów klinicznych na flukonazol. Mikologia Lekarska 3: 23-25.
• [30] Dean D.A., Burchard K.W. 1996. Fungal infections in surgical patients. American Journal Surgical 171: 374-382.
• [31] Samonis G. 2004. Portal of entry of fungi in the immunocompromised host. Mikologia Lekarska 11: 105-107.
• [32] Baran J. Jr., Mucatira B., Khatib R. 2001. Candidemia before and during the fluconacole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scandinavian Journal Infection Diseases 33: 137-139.
• [33] Gubbins P.O. 2005. The systemically acting azoles. In: Fungal infections in the immunocompromised patients. (Eds. J.R. Wingard, E.J. Analssie), Taylor & Francis Group.
• [34] Biedunkiewicz-Ziomek A., Dynowska M. 2004. Candida dubliniensis Sulivan et all – a new species in the respiratory system. Acta Mycologica 39: 7-12.
• [35] Fraser V.J., Jones M., Dunkel J. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality. Clinical Infection Diseases 15: 414-421.